Pharmacologic study of basophil histamine release induced by monocyte chemotactic protein-1 with kinase inhibitors

International Archives of Allergy and Immunology

Volumn 111, Issue 1, 1996, Pages 18-22

  Suzuki, Masaru ^a   Hirai, Koichi ^b   Kitani, Seiichi ^b   Takaishi, Toshiaki ^b   Kihara, Hidetoshi ^c   Kasahara, Tadashi ^c   Ito, Koji ^b   Morita, Yutaka ^b  

^a Kantou Central Hospital   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KEIO UNIVERSITY   (Japan)

Author keywords

Basophils; Chemokine; Histamine releasing factor; Monocyte chemotactic activating factor; Monocyte chemotactic protein 1; Myosin light chain kinase; Phosphatidylinositol 3 kinase; Protein kinase C; Tyrosine kinase; Wortmannin

Indexed keywords

GENISTEIN; HISTAMINE; IMMUNOGLOBULIN E; MONOCYTE CHEMOTACTIC PROTEIN 1; MYOSIN LIGHT CHAIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE; STAUROSPORINE; WORTMANNIN;

ARTICLE; BASOPHIL; CONTROLLED STUDY; ENZYME INHIBITION; HISTAMINE RELEASE; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0029810825     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237339     Document Type: Article

References (44)

1. Kaplan AP, Kuna P, Reddigari SR: Chemokincs as allergic mediators - relationship to histamine-releasing factors. Allergy 1994:49:495-501.
2. Thucson DO, Speck LS, Lett-Brown MA, Grant JA: Histamine-releasing activity (LIRA). I, Production by mitogen- or antigen-stimulated human mononuclear cells. J Immunol 1979:123: 626-632.
3. Thueson DO, Speck LS, Lett-Brown MA, Grant JA: Histamine-releasing activity (HRA). II. Interaction with basophils and physicochemical characterization. J Immunol 1979; 123:633-639.
4. Kaplan AP, Haak-Frcndscho M, Fauci A, Dina-rello C, Halbert F: A histamine-releasing factor from activated human mononuclear cells. J Immunol 1985;135:2027-2032.
5. Schulman FS, Liu MC, Proud D, MacGlashan DW Jr, Lichtenstein LM, Plaut M: Human lung macrophages induce histamine release from basophils and mast cells. Am Rev Respir Dis 1985:131:230-235.
6. Schulman ES, McGcttigan MC, Post TJ, Vig-derman RJ, Shapiro SS: Human monocytes generate basophil histamine-releasing activities. J Immunol 1988:140:2369-2375.
7. White MV, Kaliner MA: Neutrophils and mast cells. I, Human neutrophil-derived histamine-releasing activity. J Immunol 1987:139:1624-1630.
8. Orchard MA, Kagcy-Sobotka A, Proud D, Lichtenstein LM: Basophil histamine release induced by a substance from stimulated human platelets. J Immunol 1986;136:2240-2244.
9. Sim TC, Alam R, Forsythe PA, Welter JB, Lett-Brown MA, Grant JA: Measurement of histamine-releasing factor activity in individual nasal washings: Relationship with atopy, basophil response, and membrane-bound IgE. J Allergy Clin Immunol 1992:89:1157-1165.
10. Alam R, Welter J, Forsythe PA, Lett-Brown MA, Rankin JA, Boyars M, Grant JA: Detection of histamine release inhibitory factor- and histamine releasing factor-like activities in bron-choalveolar lavage fluids. Am Rev Respir Dis 1990;141:666-671.
11. Warner JA, Picnkowski MM, Plaut M, Norman PS, Lichtenstein LM: Identification of histamine releasing factor(s) in the late phase of cutaneous IgE-mcdiated reactions. J Immunol 1986:136:2583-2587.
12. MacDonald SM, Rafnar T, Langdon J, Lichtenstein LM: Molecular identification of an IgE-dependent histamine-releasing factor. Science 1995:269:688-690.
13. Alam R, Rozniccki J, Kuzminska B: A mononuclear cell-derived histamine-releasing factor (IIRF) in asthmatic patients. III. Further studies. Ann Allergy 1985;55:825-829.
14. Alam R, Kuna P, Rozniecki J, Kuzminska B: The magnitude of the spontaneous production of histamine-releasing factor (IIRF) by lymphocytes in vitro correlates with the state of bronchial hyperreactivity in patients with asthma. J Allergy Clin Immunol 1987:79:103-108.
15. Brunet C, Bedard PM, Lavoie A, Jobin M, Hebert J: Allergic rhinitis to ragweed pollen. II. Modulation of histamine-releasing factor production by specific immunotherapy. J Allergy Clin Immunol 1992:89:87-94.
16. Herd ZL, Bernstein DI: Antigen-specific stimulation of histamine releasing factors in diiso-cyanate-induced occupational asthma. Am J Respir Crit Care Med 1994; 150:988-994.
17. Kuna P, Alam R, Kuzminska B, Rozniccki J: The effect of prcscasonal immunotherapy on the production of histamine-releasing factor (IIRF) by mononuclear cells from patients with seasonal asthma: Results of a double-blind, placebo-controlled. randomized study. J Allergy Clin Immunol 1989;83:816-824.
18. Sampson HA, Broadbent KR, Bernhisel-Bro-adbent J: Spontaneous release of histamine from basophils and histamine-releasing factor in patients with atopic dermatitis and food hypersensitivity. N Engl J Med 1989:321:228-232.
19. Matsushima K, Larsen CO, DuBois GC, Op-penheim JJ: Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myclomonocytic cell line. J Exp Med 1989:169:1485-1490.
20. Alam R, Forsythe PA, Stafford S, Lett-Brown MA, Grant JA: Macrophage inflammatory protein- I a activates basophils and mast cells. J Exp Med 1992;176:781-786.
21. Alam R, Lett-Brown MA, Forsythe PA, Anderson-Walters DJ, Kenamore C, Kormos C, Grant JA: Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils. J Clin Invest 1992:89:723-728.
22. Bischoff SC, Krieger M, Brunner T, Dahinden CA: Monocyte chemotactic protein 1 is a potent activator of human basophils. J Exp Med 1992; 175:1271-1275.
23. Kuna P, Reddigari SR, Rucinski D, Oppenhcim JJ, Kaplan AP: Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils. J F.xp Med 1992: 175:489-493.
24. Kuna P, Reddigari SR, Schail TJ, Rucinski D, Viksman MY, Kaplan AP: RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils. J Immunol 1992;149:636-642.
25. Kuna P, Reddigari SR, Schali TJ, Rucinski D, Sadick M, Kaplan AP: Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrinc/chemokine family. J Immunol 1993; 150:1932-1943.
26. Nakano Y, Kasahara T, Mukaida N, Ko YC, Na-kano M, Matsushima K: Protection against lethal bacterial infection in mice by monocyte-chemotactic and activating factor. Infect Immun 1994;62:377-383.
27. Nakanishi S, Kakita S, Takahashi I, Kawahara K, Tsukuda E, Sano T, Yamada K, Yoshida M, Kase H, Matsuda Y, Hashimoto Y, Nonomura Y: Wortmannin. a microbial product inhibitor of myosin light chain kinase. J Biol Chern 1992; 267:2157-2163.
28. Nakanishi S, Yamada K, Iwahashi K, Kuroda K, Kase H: KT5926. a potent and selective inhibitor of myosin light chain kinase. Mol Pharmacol 1990:37:482-488.
29. Siraganian RP: An automated continuous-flow system for the extraction and fluorometrie analysis of histamine. Anal Biochem 1974:57:383-394.
30. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe SI, Itoh N, Shibuya M, Fukami Y: Ge-nistcin, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987:262:5592- 5595.
31. Thelen M, Wymann MP, Langen H: Wortmannin binds specifically to l-phosphatidylinositol 3-kinasc while inhibiting guanine nucleotide-binding protein-coupled receptor signaling in neutrophil leukocytes. Proc Natl Acad Sci USA 1994:91:4960-4964.
32. Yano H, Nakanishi S, Kimura K, Hanai N, Saitoh Y, Fukui Y, Nonomura Y, Matsuda Y: Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. J Biol Chem 1993; 268:25846-25856.
33. Tamaoki T, Nomoto H, Takahashi I, Kato Y, Mo-rintoto M, Tomita F: Staurosporine, a potent inhibitor of phospholipid/Ca dependent protein kinase. Biochem Biophys Res Commun 1986; 135:397-402.
34. Yamada K, Jelsema CL, Beaven MA: Certain inhibitors of protein serine/threonine kinases also inhibit tyrosine phosphorylation of phos-pholipase Cy I and other proteins and reveal distinct roles for tyrosine kinase(s) and protein kinase C in stimulated, rat basophilic RBL-2H3 cells. J Immunol 1992; 149:1031-1037.
35. Antoniadcs HN, Neville-Golden J, Galanopou-los T, Kradin RL, Valente AJ, Graves DT: Expression of monocyte chemoattractant protein 1 mRNA in human idiopathic pulmonary fibrosis. Proc Natl Acad Sci USA 1992;89:5371-5375.
36. Villiger PM, Terkcltaub R, Lotz M: Production of monocyte chemoattractant protein-1 by inflamed synovial tissue and cultured synoviocytes. J Immunol 1992:149:722-727.
37. Sozzani S, Luini W, Molino M, Jilek P, Bottazzi B, Cerletti C, Matsushima K, Mantovani A: The signal transduction pathway involved in the migration induced by a monocyte chemotactic cytokine. J Immunol 1991:147:2215-2221.
38. Sozzani S, Molino M, Locati M, Luini W, Cer-letti C, Vecchi A, Mantovani A: Receptor-activated calcium influx in human monocytes exposed to monocyte chemotactic protein-1 and related cytokines. J Immunol 1993; 150:1544-1553.
39. Bischoff SC, Kriegcr M, Brunner T, Rot A, Von Tscharner V, Baggiolini M, Dahindcn CA: RANTES and related ehemokines activate human basophil granulocytes through different G protein-coupled receptors. Eur J Immunol 1993:23:761-767.
40. Yatomi Y, Hazeki O, Kume S, Ui M: Suppression by wortmannin of platelet responses to stimuli due to inhibition of pleckstrin phosphorylation. Biochem J 1992:285:745-751.
41. Gelas P, Von Tscharner V, Record M, Baggiolini M, Chap H: Human neutrophil phospholi-pase D activation by N-formyl-methionyl-lcu-cylphenylalanine reveals a two-step process for the control of phosphatidylcholine breakdown and oxidative burst. Biochem J 1992:287:67-72.
42. Turner L, Ward SG, Westwick J: RANTES-acti-vated T lymphocytes. A role for phosphoinos-itide 3-kinase. J Immunol 1995; 155:2437-2444.
43. Kitani S, Teshima R, Morita Y, Ito K, Matsuda Y, Nonomura Y: Inhibition of IgE-mcdiated histamine release by myosin light chain kinase inhibitors. Biochem Biophys Res Commun 1992; 183:48-54.
44. Teshima R, Suzuki K, Ikebuchi H, Terao T: Enhancement of the phosphorylation of membrane bound myosin light chain by antigen stimulation in rat basophilic leukemia cells. Mol Immunol 1989:26:641-648.